Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

MIMETAS secures majority investment from Bruker Corporation to scale its organ-on-a-chip platforms and expand global availability.

PRIVATEAug 10, 2026•about 2 hours ago

Round Type

Venture - Series Unknown

LeidenBiotechnology

Investors

Bruker Corporation

Description

MIMETAS B.V., a Leiden-based provider of organ-on-a-chip platforms and advanced human tissue models, received a majority investment from Bruker Corporation. The amount was not disclosed. The company intends to use the funds to scale its platforms and develop integrated workflows. MIMETAS operates across North America, Europe, and Asia, serving pharmaceutical and biotechnology companies.

Company Information

Company

MIMETAS

Location

Leiden, South Holland, Netherlands

About

MIMETAS B.V. is a provider of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. They develop scalable solutions that enable researchers to study disease mechanisms and compound responses in relevant biological systems. Their offerings include OrganoPlate, OrganoReady tissue and organoid products, and contract research services. MIMETAS aims to expand the global availability of its human tissue models and integrate workflows with Bruker’s technologies.

Predictive Intelligence
Strategic

ML-powered predictions for MIMETAS's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.